EUVIMEDEUVIMED entdecken
Crossref

Optimizing Drug Therapy in Diabetic Nephropathy: A Comprehensive Review

Jeewanjot singh, Ritu, Ritu,, Shivam Jha, MD. Anees, Priyanshu Raj, Faizan Hassan, Abdul Balal, Subhajit Ojha

International Journal of Creative and Open Research in Engineering and Management · 17.04.2026 · 02 (04) · 1-9

DOI: 10.55041/ijcope.v2i4.408 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Creative and Open Research in Engineering and Management, online erschienen am 17.04.2026. Verfasst von Jeewanjot singh und 8 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Diabetic renal failure is a complex metabolic and renal pathology resulting from the interplay of hyperglycemia, hypertension, and chronic kidney disease (CKD). The management of this condition requires a comprehensive understanding of the pathophysiology, pharmacokinetic changes, and current clinical guidelines to ensure safe and effective pharmacotherapy. Renal impairment significantly alters drug absorption, distribution, metabolism, and excretion, necessitating careful dose adjustments to prevent toxicity and maintain therapeutic efficacy. The principles of dose modification involve estimating renal function using eGFR or creatinine clearance, classifying the degree of renal impairment, and applying strategies such as dose reduction, increased dosing interval, or a combination of both. The choice of antidiabetic agents should balance glycemic control and renal safety, with metformin, SGLT2 inhibitors, GLP-1 receptor agonists, and DPP-4 inhibitors being preferred options based on the stage of CKD. Insulin therapy requires individualized dosing and close monitoring to avoid hypoglycemia. Managing comorbidities such as hypertension, dyslipidemia, and cardiovascular risk is crucial, with RAAS inhibitors, statins, and antiplatelet agents being key components of the treatment plan. Clinical guidelines from ADA, KDIGO, and EASD provide evidence-based recommendations for personalized therapy, emphasizing the importance of multidisciplinary care, patient education, and regular monitoring of renal function and metabolic parameters. Future directions include the development of novel renoprotective agents, precision medicine approaches, and the integration of digital health technologies to optimize outcomes in this vulnerable patient population.

Zitieren

APA

singh, J., Ritu, Ritu,, Jha, S., Anees, M., Raj, P., Hassan, F., Balal, A., & Ojha, S. (2026). Optimizing Drug Therapy in Diabetic Nephropathy: A Comprehensive Review. International Journal of Creative and Open Research in Engineering and Management, 02(04), 1-9. https://doi.org/10.55041/ijcope.v2i4.408

Vancouver

singh J, Ritu, Ritu,, Jha S, Anees M, Raj P, et al. Optimizing Drug Therapy in Diabetic Nephropathy: A Comprehensive Review. International Journal of Creative and Open Research in Engineering and Management. 2026;02(04):1-9. doi:10.55041/ijcope.v2i4.408

BibTeX
@article{singh2026,
  author = {singh, Jeewanjot and Ritu and Ritu, and Jha, Shivam and Anees, MD. and Raj, Priyanshu and Hassan, Faizan and Balal, Abdul and Ojha, Subhajit},
  title = {Optimizing Drug Therapy in Diabetic Nephropathy: A Comprehensive Review},
  journal = {International Journal of Creative and Open Research in Engineering and Management},
  year = {2026},
  volume = {02},
  number = {04},
  pages = {1--9},
  doi = {10.55041/ijcope.v2i4.408}
}
Kostenlos starten →